Indivior Pharmaceuticals Q1 2026 Deep Dive: EPS Beats by 43.3%, Revenue Up 19%
AlphaStreet Newsdesk powered by AlphaStreet Intelligence Related Coverage INDV|EPS $0.96 vs $0.67 est (+43.3%)|Rev $317.0M|Net Income $89.0M Stock $36.78 (+7.7%) ...
Sunday, May 3, 2026
Tag: Indivior
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.